Sustanianble Medical Ecosystem
As a global leader in digital diabetes management, Sinocare actively practices the United Nations Sustainable Development Goals, promoting the synergistic development of human health and a green planet through technological innovation and humanistic care.
Sinocare continuously invests in technological innovation and engages in medical public welfare activities. We aim to effectively reduce healthcare costs, make quality diabetes management services accessible and affordable, and create sustainable value for both users and society while realizing stable business growth.
- Green Development
- Product Quality and Safety
- Technological Innovation
- Sinocare’s Sustainability
- Social Welfare
- Supply Chain Management
- Healthcare Accessibility
- Employee Well-being and Growth
Environment
Sinocare is committed to building an operational model in harmony with nature. We strengthen green development practices, establish environmental compliance systems, efficiently use energy and resources, strictly manage waste emissions, and actively carry out a series of measures to address climate change. Our goal is to balance business growth with environmental protection, promoting green and low-carbon development.
-
Awarded “National Green Factory”ISO 14001 Certification
-
Reduced greenhouse gas emissions11,195.58 tons of CO2
-
Electricity consumption savings157,209 kWh YoY
-
Reduced office paper consumption per ten thousand yuan in output YoY5%
-
Compliance rate in wastewater discharge100%
-
Recyclable and hazardous waste100% handled by qualified institutions
Social
Sinocare actively responds to social concerns, continually reaching a broader public with higher-quality and more accessible products and services. We conduct medical science education, empower grassroots medical institutions, and oaganize social welfare activities.Through technological innovation and localized services, we aim to provide precise medical solutions to more regions around the world.
Social Welfare
"Life for a Child" Project
Trividia Health provides insulin, glucose monitoring devices, and educational support
"Life for a Child" Project
57,700 children and young people, over 48 countries have benefited.
"Life for a Child" Project
Provides support for diabetic children and young people in resource-poor countries.
"Extend 30" Plan
Extends support for Type 1 diabetes patients in low-income countries to the age of 30, helping more young patients continue their education, work, and start families.
Learn More
"Life for a Child" Project
57,700 children and young people, over 48 countries have benefited.
"Life for a Child" Project
Provides support for diabetic children and young people in resource-poor countries.
Learn More
"Life for a Child" Project
Trividia Health provides insulin, glucose monitoring devices, and educational support
"Extend 30" Plan
Extends support for Type 1 diabetes patients in low-income countries to the age of 30, helping more young patients continue their education, work, and start families.
Global Assistance
-
Charity Testing
Over 3,000 events in 2024, covering 86,000 blood glucose points and 12,000 uric acid points, serving 12.6 million people. -
Training and Empowerment
Over 500 end-point clinics and health service stations, trained more than 600 rural key doctors, and enhanced the professional capabilities of 30,000 store staff. -
Overseas Training
Conducted medical education in Morocco, Serbia, the Philippines, Malaysia, Thailand, and other countries, training over 1,000 local pharmacists.
Employee Care
-
Total number of Sinocare employees in 20243,747 (other 1062 in subsidiaries)
-
Female employees63 %
-
Female management>36 %
-
Employee training coverage100 %
-
Total employee training hours44,316.83
-
Safety training (participants)508
-
Total safety training hours3,484
Governance
Sinocare has established a clear governance structure, with distinct responsibilities at each level, creating an ESG management system from strategic decision-making to execution.
Governance Framework
A three-tier ESG governance structure has been established, consisting of Board-level decision-making, ESG Committee coordination, and Working Group execution. This clear division of responsibilities ensures the efficient implementation of ESG strategies.
Robust Mechanisms
Through the Board of Directors, Supervisory Board, and Senior Management, Sinocare has built a scientific governance system characterized by coordinated operations and mutual checks and balances.
Shareholder Returns
In June 2024, Sinocare completed its 2023 profit distribution plan, issuing CNY 111 million in cash dividends to all shareholders, fulfilling its commitment to sharing development achievements with investors.
Compliance Management
We are committed to building a corporate culture that integrates business ethics and regulatory compliance, ensuring sustainable development through institutional optimization and standardized management.